PH12015000297B1 - Pharmaceutical combination preparation - Google Patents

Pharmaceutical combination preparation

Info

Publication number
PH12015000297B1
PH12015000297B1 PH12015000297A PH12015000297A PH12015000297B1 PH 12015000297 B1 PH12015000297 B1 PH 12015000297B1 PH 12015000297 A PH12015000297 A PH 12015000297A PH 12015000297 A PH12015000297 A PH 12015000297A PH 12015000297 B1 PH12015000297 B1 PH 12015000297B1
Authority
PH
Philippines
Prior art keywords
aspirin
layer
coating
clopidogrel
combination preparation
Prior art date
Application number
PH12015000297A
Other versions
PH12015000297A1 (en
Inventor
Youn Woong Choi
Byung Gu Min
Dea Chul Ha
Sang Min Cho
Hee Yong Song
Hee Chan Park
Jae Sang Jang
In Ho Kwon
Ah Young Kim
Seung Jin Yang
Keoun Hui Yu
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of PH12015000297B1 publication Critical patent/PH12015000297B1/en
Publication of PH12015000297A1 publication Critical patent/PH12015000297A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Abstract

The present invention relates to a combination preparation containing clopidogrel and aspirin, and to a combination preparation which is stable and has ensured bioavailability, wherein a granule obtained by coating a clopidogrel layer with a protective layer for rapid release and a granule obtained by coating an aspirin layer with an enteric layer are filled in a capsule. The present invention prevents physical contact between clopidogrel and aspirin, which fundamentally prevents the eutectic phenomenon thereof, thereby preventing changes in the content, dissolution behavior, and bioequivalence of a preparation, in the short term, and improving stability thereof, in long term, and preventing damage to the stomach walls by coating aspirin with an enteric layer.
PH12015000297A 2015-05-29 2015-09-03 Pharmaceutical combination preparation PH12015000297A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150076665A KR101764785B1 (en) 2015-05-29 2015-05-29 Pharmaceutical combination preparation

Publications (2)

Publication Number Publication Date
PH12015000297B1 true PH12015000297B1 (en) 2018-02-12
PH12015000297A1 PH12015000297A1 (en) 2018-02-12

Family

ID=57440503

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015000297A PH12015000297A1 (en) 2015-05-29 2015-09-03 Pharmaceutical combination preparation

Country Status (3)

Country Link
KR (1) KR101764785B1 (en)
PH (1) PH12015000297A1 (en)
WO (1) WO2016195153A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102055301B1 (en) * 2018-01-19 2019-12-12 김한수 Toothpsate composites typed effervescent and that of manufacturing method
CN114469962A (en) * 2021-12-16 2022-05-13 海口天行健药物研究有限公司 Preparation method of L-arginine aspirin and L-arginine aspirin capsule
CN115770229A (en) * 2022-12-13 2023-03-10 山东诺明康药物研究院有限公司 Clopidogrel sulfate aspirin tablet and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101237868A (en) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 Nanoparticulate clopidogrel and aspirin combination formulations
KR100809903B1 (en) * 2006-09-05 2008-03-06 주식회사유한양행 Stabilized clopidogrel-containing particles, processes for preparing the same, and pharmaceutical compositions comprising the same
KR100949273B1 (en) * 2008-02-22 2010-03-25 한올제약주식회사 Combined Formulation
KR101675501B1 (en) 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 Combination of Clopidogrel and Aspirin
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
KR101502588B1 (en) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 Combination of Clopidogrel and Aspirin

Also Published As

Publication number Publication date
KR20160141314A (en) 2016-12-08
WO2016195153A1 (en) 2016-12-08
KR101764785B1 (en) 2017-08-07
PH12015000297A1 (en) 2018-02-12

Similar Documents

Publication Publication Date Title
IL286518A (en) Capsules and capsule coatings for gastric residence dosage forms
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
CL2015002148A1 (en) Pharmaceutical formulations resistant to improper handling
ZA201706300B (en) Capsule for the preparation of infused or soluble beverages
PH12016500121A1 (en) Pharmaceutical tablet comprising acetylsalicyclic acid and clopidogrel
PL3313755T3 (en) Single-dose capsule for the preparation of beverages
IN2015DN04161A (en)
PH12015000297B1 (en) Pharmaceutical combination preparation
EP3178473C0 (en) Acid resistant capsule shell and its preparation process
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
PL3463310T3 (en) Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
PT3060203T (en) Effervescent tablet containing high level of aspirin
DK3641730T3 (en) Particle and pharmaceutical composition comprising an insoluble dual core shell structure camptothecin compound and process for its preparation
PL3102187T3 (en) Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
DK3368017T3 (en) Optimized mesalazine containing high dose tablet
IL262059A (en) Film-coated tablet having high chemical stability of active ingredient
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
EA202090913A1 (en) COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON
HK1220113A1 (en) Pharmaceutical soft gelatin capsule dosage form
GB201402457D0 (en) Capsules containing high doses of phospholipids
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
FR3027395B1 (en) COMPOSITION FOR IMMUNO-ENZYMATIC IMMUNOFLUORESCENCE ASSAY AND USES THEREOF
PL3328385T3 (en) Dosage form of vinca alkaloid drug
WO2015114655A3 (en) Modified release tablet of pregabalin